Research Options:

Week of Expected Pricing 5/4/2023
Company Name KENVUE INC
Proposed Ticker KVUE
CUSIP 49177J102
Business Description The world’s largest pure-play consumer health company by revenue with $15.1 billion in net sales in 2021. We combine the power of science with meaningful human insights and digital-first capabilities, which we believe empowers approximately 1.2 billion people to live healthier lives every day. Our differentiated portfolio of iconic brands—including Tylenol, Neutrogena, Listerine, Johnson’s, Band-Aid, Aveeno, Zyrtec and Nicorette—is built for moments that uniquely matter to our consumers and, we believe, drives positive health outcomes around the world.
Lead Underwriter BofA Securities, Inc, Goldman Sachs & Co. LLC, J.P. Morgan Securities LLC
Co-Managers Academy Securities, Inc, BBVA Securities Inc, BNP Paribas Securities Corp., Citigroup Global Markets Inc, Deutsche Bank Securities Inc., HSBC Securities (USA) Inc., Independence Point Securities LLC, ING Financial Markets LLC, Intesa Sanpaolo S.p.A., R. Seelaus & Co., LLC, RBC Capital Markets, LLC, Samuel A. Ramirez & Company, Inc., Santander US Capital Markets LLC, Siebert Williams Shank & Co., LLC, UBS Investment Bank, UniCredit Capital Markets LLC
Initial Shares 15,12,04,000
Revised Initial Shares 17,28,12,560
Initial Price $20.00-$23.00
Revised Price N/A
Final Price $22.00
Final Ticker KVUE

 

 

   
  © 2024 ICE Data Services. All rights reserved.